Promising trial for Alzheimer's treatment

Name: Promising trial for Alzheimer's treatment
Uploaded: 2023-05-12T01:31:17Z
Duration: 3 min 3 s
Description: Eli Lilly last week announced the results of a Phase 3 trial on its experimental drug called Donanemab. The latest drug trial in a new class of Alzheimer’s drugs gives researchers and advocates renewed hope of slowing the progression of the brain disease.

Eli Lilly last week announced the results of a Phase 3 trial on its experimental drug called Donanemab. The latest drug trial in a new class of Alzheimer’s drugs gives researchers and advocates renewed hope of slowing the progression of the brain disease.

Posted May 11, 2023 8:31pm CDT